Tag archive for ‘Deutsche Bank Securities LLC’
Gali Weinreb On Monday, June 9th, 2014

VBL Therapeutics files for $75 million Nasdaq IPO

– VBL is developing drugs for the treatment of cancer and inflammatory diseases. On Friday,  VBL Therapeutics Ltd. (formerly Vascular Biogenics) published a draft prospectus with the US Securities More...

Wordpress site Developed by Fixing WordPress Problems